Time to Control Retinal Fluid With Faricimab in DME, says Dr. Aleksandra Rachitskaya.

Published Date: 13 Aug 2023

According to a post hoc analysis of YOSEMITE/RHINE that was presented at ASRS 2023, faricimab is associated with a quicker absence of retinal fluid and fewer injections compared to aflibercept in eyes with DME.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reducing social media to an hour a day boosts young people's self-image.

2.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

3.

The pandemic had little impact on mental health symptoms.

4.

FDA Approves New Bladder Cancer First-Line Standard of Care.

5.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot